EUCTR2005-005084-29-GB进行中（未招募）不适用
The effect of intensive lipid lowering on markers of inflammation in patients with stable coronary artery disease. - Intensive lipid lowering
Chief Scientitst Office0 个研究点开始时间: 2005年12月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Stable coronary artery disease
- •Patients aged 18-80 years
- •Total choleterol >5 mmol/l
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Acute coronary syndrome within 3 months
- •Previously documented statin-intolerance
- •Hepatic dysfunction (Childs Pugh score >5)
- •Significant comorbidity associated with reduce longevity
- •Participation in another clinical trial
研究者
相似试验
已完成
不适用
The effecs of intensive lipid-lowering therapy on the progression of atherosclerotic kidney diseasechronic kidney diseaseJPRN-UMIN000021356niversity, School of Medicine40
已完成
不适用
Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound StudyAcute Coronary SyndromeJPRN-UMIN000003620Hyogo College of Medicine Cardiovascular Division50
招募中
不适用
Effects of lipid lowering on endothelial functioDiseases of the circulatory systemKCT0001730Wonkwang University Hospital81
已完成
不适用
Effects of high- versus LOw-intensity lipid-lowering treatment in patients undergoing serial CoronAry compuTEd tomography angiography:Results of the multi-center LOCATE studyI25Chronic ischaemic heart diseaseDRKS00031954GRN-Klinikum Weinheim216
尚未招募
4 期
Intensive lipid and blood pressure lowering and cardiovascular outcome: Randomised controlled trial on patients with coronary artery disease and type 2 diabetesJPRN-UMIN000003548Department of Clinical Pharmacology & Therapeutics, University of the Ryukyus Graduate School of Medicine1,000